The solution structure of the anti-HIV chemokine vMIP-II
about
Structural rearrangement of human lymphotactin, a C chemokine, under physiological solution conditionsStructure/function of human herpesvirus-8 MIP-II (1-71) and the antagonist N-terminal segment (1-10)CCR2 and CCR5 receptor-binding properties of herpesvirus-8 vMIP-II based on sequence analysis and its solution structureMonomeric solution structure of the prototypical 'C' chemokine lymphotactinNMR structure of the pseudo-receiver domain of CikAA novel CXCR4-selective high-affinity fluorescent probe and its application in competitive binding assaysVirokines: novel immunomodulatory agents.Crystal structure and structural mechanism of a novel anti-human immunodeficiency virus and D-amino acid-containing chemokine.Drug discovery research targeting the CXC chemokine receptor 4 (CXCR4).Characterization of structure, dynamics, and detergent interactions of the anti-HIV chemokine variant 5P12-RANTES.Biology and clinical relevance of chemokines and chemokine receptors CXCR4 and CCR5 in human diseases.Characterization of the interactions of vMIP-II, and a dimeric variant of vMIP-II, with glycosaminoglycans.The binding surface and affinity of monomeric and dimeric chemokine macrophage inflammatory protein 1 beta for various glycosaminoglycan disaccharides.Biophysical and Computational Studies of the vCCI:vMIP-II Complex.Allosterism in human complement component 5a ((h)C5a): a damper of C5a receptor (C5aR) signaling.Structural and functional characterization of human CXCR4 as a chemokine receptor and HIV-1 co-receptor by mutagenesis and molecular modeling studies.Elucidating the structural mechanisms for biological activity of the chemokine family.
P2860
Q24292437-A527C597-05DE-45C8-8986-7A25C568AA17Q27629348-AAD252AD-4EE8-42F9-AA32-C02D7F783A08Q27631819-B2CE25A1-ECE7-4103-B830-515847214165Q27635401-3A814D05-A005-4C0C-BE30-0BED2F2700C6Q27643902-08166B51-005A-4FC3-A945-DCB77AF63929Q34089069-0B71483A-00D3-4ADD-A7F7-2FC419F55196Q34451942-B79A2836-176D-42ED-85BA-7E76EFD506B6Q36099267-02FC3622-7AD7-46A4-8269-6360C143900FQ36334083-4165950F-4523-4A94-A847-26B1E15E5C79Q37368217-D720F6A8-F108-4F48-8107-2F888B2A74A8Q37599363-4510AE55-3B62-4679-A949-69FCF3A9553FQ38341658-E1FE5189-FB59-455F-8C08-6DF3626448EAQ38361416-72FF8B95-9BC4-44E8-BE73-2478285243F9Q40081462-DA1680DE-2DEC-469C-9D27-9AD8E1E4A830Q40695140-C4027993-DE64-4259-9FD9-30749A95865BQ40781201-EB38DBD9-E5C1-4D34-A13A-3B1E21FA7AB7Q52066466-FD453DD0-BD42-46CB-9434-EF6DC134397C
P2860
The solution structure of the anti-HIV chemokine vMIP-II
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
The solution structure of the anti-HIV chemokine vMIP-II
@ast
The solution structure of the anti-HIV chemokine vMIP-II
@en
The solution structure of the anti-HIV chemokine vMIP-II
@nl
type
label
The solution structure of the anti-HIV chemokine vMIP-II
@ast
The solution structure of the anti-HIV chemokine vMIP-II
@en
The solution structure of the anti-HIV chemokine vMIP-II
@nl
prefLabel
The solution structure of the anti-HIV chemokine vMIP-II
@ast
The solution structure of the anti-HIV chemokine vMIP-II
@en
The solution structure of the anti-HIV chemokine vMIP-II
@nl
P2093
P2860
P356
P1433
P1476
The solution structure of the anti-HIV chemokine vMIP-II
@en
P2093
P2860
P304
P356
10.1110/PS.8.11.2270
P577
1999-11-01T00:00:00Z